The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDODS.L Regulatory News (DODS)

  • There is currently no data for DODS

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

26 Jul 2006 07:01

Huveaux PLC26 July 2006 26 July 2006 HUVEAUX PLC Interim Results for the six months ended 30 June 2006 and acquisition of Political Wizard Highlights • Turnover up 122% to £20.1 million • Pre-tax profit up 133% to £1.3 million • EBITDA margin up from 7.8% to 8.9% at £1.8 million • Normalised EPS doubled to 0.68 pence* • Excellent performance from the JBB Sante and Epic acquisitions • Key strategic steps delivered ahead of schedule • Acquisition of Political Wizard, a leading online political monitoring business, for £4.88 million in cash • Outlook for continued strong progress in the second half of 2006 Summary of Results Six months to Six months to 30 June 2006 30 June 2005£'000 Unaudited Unaudited and Restated** Turnover 20,075 9,046Profit before tax 1,296 557EBITDA*** 1,780 707Normalised earnings per share (basic)* 0.68p. 0.34p.Earnings per share (basic) 0.62p. 0.34p. * Stated before amortisation of goodwill of £84,000 (2005 nil). ** Restated for change in accounting policy in accordance with the introductionof FRS 20: 'Share-based Payment.' The charge for the six months to 30 June 2005was £78,000. *** EBITDA is calculated as operating profit before amortisation, depreciationand exceptional items. John van Kuffeler, Executive Chairman of Huveaux, commented: "Strong growth in revenue and profits has been driven principally by theacquisition of Epic and JBB Sante in 2005. Following their successfulintegration, we have been able to deliver all our strategic steps for 2006 aheadof schedule. The first half also reflects a solid performance in our otherbusinesses. The acquisition of Political Wizard will further strengthen our position in thestrategically important area of online political monitoring, which is a growingand lucrative market in both the UK and EU. This will provide an enhancedplatform from which we can continue to build a substantial business, as part ofour highly successful Political Division, both in the UK and internationally. The outlook for Huveaux in the second half of 2006 remains positive and we arewell placed to deliver continued strong progress for the full year. The Boardexpects the acquisition of Political Wizard to enhance Huveaux's earnings in thefirst full financial year of ownership." For further information, please contact: Huveaux John van Kuffeler, Executive Chairman 020 7245 0270 Gerry Murray, Chief Executive Officer Dan O'Brien, Group Finance Director Finsbury Katie Lang 020 7251 3801 Don Hunter A presentation for analysts will be held at 9.30am today at the offices ofDresdner Kleinwort, 30 Gresham Street, London EC2V 7PG. Coffee will be availablefrom 9.15am. Note to Editors: Huveaux was formed in 2001 with the objective of building a substantial,high-quality publishing and media group. It is now twenty fold the size when itfirst listed on AIM. The Group consists of three Divisions each of which has strong brands and marketleading positions: Political Division comprises Dod's Parliamentary Companion, The House Magazine,Epolitix.com and numerous other magazine titles and revenue-generating websites.It is the market leader in Political business-to-business publishing in the UKand the EU. Learning Division comprises Epic, the UK market leader in e-learning, TheTraining Journal magazine and seminar business, Lonsdale Revision Guides forschools and the highly acclaimed Westminster Explained conferences and seminars. Healthcare Division, based in France, comprises Panorama du Medecin, a leadingweekly magazine for French doctors, Le Concours Medical and La Revue duPraticien, both market leading Continuing Medical Education magazines, Egora.fr,the leading medical information website, and a number of other magazines and amedical conference business. Huveaux has now completed ten successful acquisitions over the past four yearsand employs more than 450 staff in London, Paris, Brussels and four UK regionaloffices. Further information about Huveaux can be found at www.huveauxplc.com The name Huveaux is a trademark of Huveaux PLC. All other trademarks mentionedherein are the property of Huveaux's respective subsidiary companies. All rightsreserved. OPERATING AND FINANCIAL REVIEW Group Performance The first half of 2006 saw substantial growth in sales, profits and earnings pershare driven principally by contributions from Epic and JBB Sante which wereacquired in August and October 2005 respectively. The integration of thesecompanies is now complete and is helping to drive significant strategic progressacross the Group. In March, we confirmed our strategic objectives and identified the areas offurther investment in each of our three Divisions. Excellent progress has beenmade and many of the new launches planned for 2006 are now largely complete. Inmany cases, these launches have combined Huveaux generated content withEpic-generated digital delivery to further increase the Group's digitalfootprint and revenues. Sales increased to £20.1 million from £9.0 million in 2005 and EBITDA increasedfrom £0.7 million to £1.8 million. Normalised earnings per share doubled to 0.68pence from 0.34 pence. Operating Review • Political Division The Political Division maintained the significant performance improvementachieved during the 2005 General Election period, with like-for-like revenueunchanged at £4.1 million. The first half was also marked by a record number ofsuccessful new launches including: - Dod's Polling A quarterly poll of MPs to enable organisations to gauge the perceptions andopinions of parliamentarians on key issues - EU Political Monitoring A vital new service for organisations affected by the European Union providingmonitoring of all EU institutions on legislation and policy - The Parliament Regional Review Reflecting the work of the influential Committee of the Regions, this newquarterly magazine provides an authoritative forum to examine the impact of EUinvestment in the regions - Vacher's Parliamentary Profiles A new publication that provides an impartial, authoritative and detailed profileon every Member of Parliament within the United Kingdom - Dod's Westminster Contacts A pocket book with over 1,500 contacts within Westminster providing essentialpolitical contact information - Who's Who in Public Affairs The first single work of reference available for organisations profiling all keypeople that work in the public affairs departments across the UK These new products and the continued progress of our existing titles provide agood foundation for revenue and profit growth across the Division in the secondhalf. In addition, development work continues on our Civil Service portal due forlaunch at the year-end. • Learning Division The Learning Division had an excellent first half performance with revenuesdoubling to £7.8 million, driven principally by the contribution from Epic. Epic enjoyed an encouraging flow of new business from both existing and newcustomers. Its performance also included the following notable contract wins: - the first £1.0 million plus new contract in Epic's history from a bluechip financial services company; - a Government department contract to project manage and deliver itsoverall learning needs. This contract marks success in our targeted entry intothe higher value managed learning services arena; - the establishment of Epic Professional, a new operating unit aimed atproviding a range of off-the-shelf e-learning products. Initially, these willfocus on the fast-moving and increasingly demanding compliance and regulatorymarkets and build on Huveaux-owned intellectual property, skills and content.Epic Professional has recently launched products in Absenteeism and Ageism aswell as a modular Leadership programme; and - an e-learning contract from a French Healthcare Agency won following ajoint bid proposal from Huveaux France and Epic. This is the first major successarising from the close working relationship which has been forged between thesetwo Group businesses in order to deliver bespoke e-learning healthcare productsand take advantage of opportunities in the broader local market of ContinuingMedical Education (CME). These demonstrate our progress in expanding Epic's product and service offeringsbeyond its original bespoke e-learning business model and into higher qualityearnings streams. From September, the new National Science curriculum in schools will beintroduced in England, Wales and Northern Ireland. Consequently, Lonsdale had aquiet first half successfully selling all its old curriculum products prior tothe launch of its 35 new titles across the summer. We expect the launch of thesenew titles to drive significant growth in revenue and profits during the secondhalf. We have developed a prototype online testing system at Lonsdale using Epictechnology and expertise which is presently undergoing customer trials. At Fenman, we have continued to maintain our profit levels and grow the TrainingJournal and professional training events side of the business. This has beenachieved while reducing our reliance on the sale of videos and convertingcontent into an e-learning format. • Healthcare Division The Healthcare Division's sales amounted to £8.2 million, compared to £0.8million in the first half of last year. This was driven by the acquisition ofJBB Sante which is now trading as Huveaux France as part the HealthcareDivision. Several strategic milestones have been achieved in the first half of2006 that position the business well for the second half and beyond: - Panorama du Medecin has been successfully relaunched and its market sharehas increased from 14% to 16%; - Le Concours Medical has been relaunched as a fortnightly magazine with anew editorial proposition; - details of CME legislation was published in June, requiring doctors andother healthcare professionals to keep abreast of new developments bysubscribing to medical journals and undertaking regular training, were publishedin June. All our magazines have been provisionally allocated CME points by theFrench Ministry of Health. When confirmed, we will hold the highest annualpoint-scoring portfolio of CME-accredited magazines in the French medicalpublishing sector; - we have designed a new bespoke CME product for the treatment ofalcoholism which is the first of its kind to be approved by the French Ministryof Health; and - the Healthcare Division and Epic have successfully negotiated ane-learning project with the French National Institute of Cancer Research. These achievements demonstrate that our strategic objectives have been deliveredwell ahead of schedule and that we are in an exceptionally strong marketposition. We anticipate continued strong performance in the second half of 2006 with thebenefit of CME sales contributing to growth during 2007. Financial Review Net debt amounted to £9.3 million at 30 June 2006. During the first half, wesettled £0.9 million of restructuring costs relating to previous acquisitionsand paid £1.5 million in satisfaction of the 2005 final dividend. Proforma netdebt will now increase to £14.7 million following the financing of the PoliticalWizard acquisition announced today. This still represents a modest level ofgearing, a proforma net debt to EBITDA of 2.5 times, and a strong position fromwhich to finance any future requirements. In line with the introduction of FRS 20: 'Share-based Payment', the Company haschanged its accounting policy to recognise the cost of share option awards toemployees. The amount recognised in the profit and loss account for the firsthalf of 2006 is £117,000 (2005: £78,000). The Company is currently undertaking an initial review of the impact of adoptingIFRS which it is required to adopt in line with all AIM-listed companies for thefinancial year commencing 1 January 2007. A further update will be provided inthe Company's results for the year ended 31 December 2006. Outlook The second half of each financial year is an important period for the businessgiven the start of both the academic and parliamentary years in September andOctober respectively. The coming second half will be particularly important dueto the 35 new titles being launched by Lonsdale in the summer to cover theintroduction of the new National Science curriculum in schools this September. We have made excellent progress on our strategic and operational goals duringthe first half leaving us well placed for strong progress in the second half of2006. The position of the Group will be further enhanced by the acquisition ofPolitical Wizard which was announced today. The Board expects this acquisitionto enhance Huveaux's earnings in the first full financial year of ownership. Acquisitions remain an important part of Huveaux's growth strategy and we arecurrently in negotiations for a further complementary acquisition. HUVEAUX PLCCONSOLIDATED PROFIT AND LOSS ACCOUNT For the six For the six For the months months year ended ended ended 30 June 30 June 31 December 2006 2005 2005 as restated* as restated* Unaudited Unaudited Audited Note £ 000s £ 000s £ 000s Turnover 3 20,075 9,046 27,736 Cost of sales (12,443) (5,370) (15,646) Gross profit 7,632 3,676 12,090 Administrative expenses (6,100) (3,123) (7,943) Amortisation of goodwill (84) - (56) Exceptional items - - (1,903) Total operating expenses (6,184) (3,123) (9,902) Total operating profit 3 1,448 553 2,188 Other interest receivable and similar income 46 27 111 Interest payable and similar charges (198) (23) (105) Exceptional items - - (231) Interest payable and similar charges (198) (23) (336) Profit on ordinary activities before taxation 1,296 557 1,963 Tax on profit on ordinary activities 4 (434) (191) (427) Profit for the financial period 862 366 1,536 *see notes 1 and 10 Earnings per share - basic 5 0.62 p 0.34 p 1.31 p Earnings per share - diluted 5 0.61 p 0.34 p 1.30 p Adjusted basic earnings per share before exceptional items and goodwill amortisation 5 0.68 p 0.34 p 2.62 p HUVEAUX PLCCONSOLIDATED BALANCE SHEET As at As at As at 30 June 30 June 31 December 2006 2005 2005 as restated* as restated* Unaudited Unaudited Audited Note £ 000s £ 000s £ 000s Fixed assets Intangible assets 6 50,999 38,046 51,083 Tangible assets 1,302 836 1,000 52,301 38,882 52,083 Current assets Stocks 1,941 1,287 2,150 Debtors 12,025 6,317 12,672 Cash at bank and in hand 1,033 625 2,678 14,999 8,229 17,500 Creditors: Amounts falling due within one year (13,907) (7,565) (13,919) Net current assets 1,092 664 3,581 Total assets less current liabilities 53,393 39,546 55,664 Creditors: Amounts falling due after more than one year (9,328) - (10,065) Provision for liabilities and charges (615) - (1,552) Net assets 43,450 39,546 44,047 Capital and reserves Called-up equity share capital issued 14,017 10,761 14,017 Share premium account 26,795 26,726 26,795 Merger reserve 409 409 409 Profit and loss account 1,883 1,516 2,597 Share-based payments reserve 346 134 229 Equity shareholders' funds 7 43,450 39,546 44,047 *see notes 1 and 10 HUVEAUX PLCCONSOLIDATED CASH FLOW STATEMENT For the six For the six For the months months year ended ended ended 30 June 30 June 31 December 2006 2005 2005 as restated* as restated* Unaudited Unaudited Audited Note £ 000s £ 000s £ 000s Reconciliation of operating profit to net cash flow from operating activities Operating profit 1,448 553 2,188 Depreciation charges 248 154 400 Share-based payments charges 117 78 173 Amortisation charges 84 - 56 Cash flow relating to restructuring (937) - (1,349) provisions Decrease in stocks 209 25 409 Decrease/(increase) in debtors 647 (1,741) (2,977) (Decrease)/increase in creditors (1,127) 1,284 2,273 Net cash inflow from operating activities 689 353 1,173 Cash flow statement Cash flow from operating activities 689 353 1,173 Returns on investments and servicing of finance 8 (152) 4 (225) Taxation - - (385) Capital expenditure and financial investment 8 (623) (193) (359) Acquisitions and disposals 8 - (1,571) (9,849) Equity dividends paid (1,542) (1,076) (1,076) Cash outflow before financing (1,628) (2,483) (10,721) Financing 8 - (3) 10,389 Decrease in cash in the period 9 (1,628) (2,486) (332) *see notes 1 and 10 HUVEAUX PLCNotes to the Accounts30 June 2006 1 These accounts comply with relevant accounting standards and have been prepared on a consistent basis using the accounting policies set out in the Annual Report 2005, as amended by the introduction of FRS 20 Share-based Payment, the effect of which is set out in note 10. 2 The financial information included in this document does not constitute statutory accounts within the meaning of section 240 of the Companies Act 1985. The accounts for the year ended 31 December 2005, which have been filed with the Registrar of Companies, received an unqualified audit report and did not contain a statement under section 237(2) or (3) of the Companies Act 1985. The financial information contained herein in respect of the six month periods to 30 June 2006 and to 30 June 2005 is unaudited. 3 Segmental information The tables below set out information on each of the Group's industry segments and geographic areas of operation. Period ended Period ended Year ended 30 June 30 June 31 December 2006 2005 2005 Unaudited Unaudited Audited £ 000s £ 000s £ 000s Group turnover by geographical destination Political United Kingdom 3,412 3,269 8,214 Continental Europe and rest of the world 700 1,108 1,507 4,112 4,377 9,721 Learning United Kingdom 7,608 3,791 10,880 Continental Europe and rest of the world 192 121 344 7,800 3,912 11,224 Healthcare United Kingdom - - - Continental Europe and rest of the world 8,163 757 6,791 8,163 757 6,791 20,075 9,046 27,736 3 Segmental information (continued) Period ended Period ended Year ended 30 June 30 June 31 December 2006 2005 2005 *as restated *as restated Unaudited Unaudited Audited £ 000s £ 000s £ 000s Total operating profit/(loss) Political United Kingdom 233 381 1,190 Continental Europe and rest of the world 91 129 237 324 510 1,427 Learning United Kingdom 1,207 758 2,109 Continental Europe and rest of the world 29 24 29 1,236 782 2,138 Healthcare United Kingdom - - - Continental Europe and rest of the world 1,024 (70) 277 1,024 (70) 277 Head Office United Kingdom (1,136) (669) (1,654) Continental Europe and rest of the world - - - (1,136) (669) (1,654) 1,448 553 2,188 Head office costs include amortisation of goodwill totalling £84,000 (period ended 30 June 2005: £nil; year ended 31 December 2005: £56,000) and charges for share-based payments totalling £117,000 (period ended 30 June 2005: £78,000; year ended 31 December 2005: £173,000). 3 Segmental information (continued) As at As at As at 30 June 30 June 31 December 2006 2005 2005 *as restated *as restated Unaudited Unaudited Audited £ 000s £ 000s £ 000s Net assets/(liabilities) Political United Kingdom 23,474 23,890 23,337 Continental Europe and rest of the world - - - 23,474 23,890 23,337 Learning United Kingdom 17,791 13,284 17,764 Continental Europe and rest of the world - - - 17,791 13,284 17,764 Healthcare United Kingdom - - - Continental Europe and rest of the world 1,739 2,636 1,945 1,739 2,636 1,945 Head Office United Kingdom 446 (264) 1,001 Continental Europe and rest of the world - - - 446 (264) 1,001 43,450 39,546 44,047 *see notes 1 and 10 4 Taxation The taxation charge for the six months ended 30 June 2006 is based on the expected annual tax rate. 5 Earnings per Share Period ended Period ended Year ended 30 June 30 June 31 December 2006 2005 2005 Unaudited Unaudited Audited £ 000s £ 000s £ 000s Profit attributable to shareholders 862 366 1,536 Add: exceptional items - - 2,134 Add: amortisation of goodwill 84 - 56 Less: tax in respect of exceptional - - (640) items Adjusted profit attributable to 946 366 3,086 shareholders 2006 2005 2005 Shares Shares Shares Weighted average number of shares In issue during the year - basic 140,170,496 107,108,770 117,677,253 Dilutive potential ordinary shares 513,854 21,761 421,610 Diluted 140,684,350 107,130,531 118,098,863 Earnings per share - basic (pence) 0.62 0.34 1.31 Earnings per share - diluted (pence) 0.61 0.34 1.30 Adjusted earnings per share before exceptional items and amortisation of goodwill - 0.68 0.34 2.62 basic (pence) 6 Intangible fixed assets Period Period Year ended ended ended 30 June 30 June 31 December 2006 2005 2005 Unaudited Unaudited Audited £ 000s £ 000s £ 000s Cost & Net book value Opening balance 51,083 38,046 38,046 Additions - - 29 Additions through acquisition - - 13,064 Amortisation charged in year (84) - (56) Closing balance 50,999 38,046 51,083 7 Reconciliation of movements in equity shareholders' funds Total equity shareholders' funds Unaudited £ 000s Profit for the period 862 Payment of 2005 dividend (1,542) Share-based payments charges 117 Currency translation differences on foreign currency net investments (34) Net decrease in shareholders' funds (597) Equity shareholders' funds at 31 December 2005 (as restated - see note 10) 44,047 Equity shareholders' funds at 30 June 2006 43,450 8 Analysis of cash flows Period ended Period ended Year ended 30 June 30 June 31 December 2006 2005 2005 Unaudited Unaudited Audited £ 000s £ 000s £ 000s Returns on investment and servicing of finance Interest and similar income received 46 27 111 Interest and similar expenses paid (198) (23) (336) (152) 4 (225) Capital expenditure and financial investment Purchase of tangible fixed assets (623) (193) (358) Purchase of intangible fixed assets - - (1) (623) (193) (359) Acquisitions and disposals Purchase of subsidiary undertakings and assets - - (18,224) Lonsdale deferred consideration paid - (1,100) (1,100) PCL deferred consideration paid - (471) (471) Cash acquired on acquisition of subsidiary - - 9,946 - (1,571) (9,849) Financing Debt due within one year: Increase in short-term borrowing - - 9,016 Repayment of secured loan - - (8,500) Debt due after more than one year: New secured loan repayable from 2007 to 2012 - - 9,807 Expenses recouped in connection with share issue - (3) 66 - (3) 10,389 9 Analysis of net debt Period ended Period ended Year ended 30 June 30 June 31 December 2006 2005 2005 Unaudited Unaudited Audited £ 000s £ 000s £ 000s Cash at bank and in hand Opening balance 2,678 3,120 3,120 Cash flow during the period (1,628) (2,486) (332) Exchange movement (17) (9) (110) Closing balance 1,033 625 2,678 Debt due within one year Opening balance (516) - - Cash flow during the period - - (516) Exchange movement (2) - - Reclassification of debt (518) - - Closing balance (1,036) - (516) Debt due after one year Opening balance (9,807) - - Cash flow during the period - - (9,807) Exchange movement (39) - - Reclassification of debt 518 - - Closing balance (9,328) - (9,807) Net (debt)/funds (9,331) 625 (7,645) 10 Adoption of FRS 20 Share-based Payment FRS 20 Share-based Payment requires that the fair value of share awards granted to employees is assessed at grant date and is charged to the profit and loss account over the vesting period based on the expectation of the number of shares which the Directors consider likely to vest, with a corresponding increase in equity. The fair value of the options granted is measured using an option pricing model, taking into account the terms and conditions upon which the options were granted. Deferred tax is recognised where it is likely that share relief will be available on the difference between exercise price and market price at the balance sheet date. The amount recognised in profit before tax for the six month period ended 30 June 2006 is £117,000. The effect of the adoption of FRS 20 on equity shareholders' funds and profit after tax for the comparative periods is shown below. Equity Equity Shareholders' Shareholders' funds funds At 30 June At 31 December 2005 2005 £ 000s £ 000s As previously stated 39,546 44,041 Deferred - 6 tax asset As restated 39,546 44,047 Profit after Profit after tax tax Period ended Year ended 30 June 31 December 2005 2005 £ 000s £ 000s As previously stated 445 1,703 Share-based payments charge (78) (173) Movement on deferred tax asset (1) 6 As restated 366 1,536 11 Reconciliation between operating profit and non-statutory measure The following tables reconcile operating profit as stated above to EBITDA, a non-statutory measure which the Directors believe is the most appropriate measure in assessing the performance of the Group. EBITDA is defined by the Directors as being earnings before interest, tax, depreciation, amortisation and exceptional items. Period ended 30 June 2006 Political Learning Healthcare Head Office Total £ 000s £ 000s £ 000s £ 000s £ 000s Operating profit 324 1,236 1,024 (1,136) 1,448 Amortisation - - - 84 84 Depreciation 111 89 34 14 248 EBITDA 435 1,325 1,058 (1,038) 1,780 Included within Head Office costs are share-based payments charges of £117,000. Year ended 31 December 2005 Political Learning Healthcare Head Office Total £ 000s £ 000s £ 000s £ 000s £ 000s Operating profit 1,427 2,138 277 (1,654) 2,188 Amortisation - - - 56 56 Depreciation 218 104 52 26 400 Exceptional items 155 373 1,152 223 1,903 EBITDA 1,800 2,615 1,481 (1,349) 4,547 Included within Head Office costs are share-based payments charges of £173,000. Period ended 30 June 2005 Political Learning Healthcare Head Office Total £ 000s £ 000s £ 000s £ 000s £ 000s Operating profit 510 782 (70) (669) 553 Amortisation - - - - - Depreciation 93 25 23 13 154 EBITDA 603 807 (47) (656) 707 Included within Head Office costs are share-based payments charges of £78,000. This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
20th Apr 20214:05 pmRNSHolding(s) in Company
16th Apr 202111:30 amRNSResult of General Meeting
1st Apr 20217:00 amRNSPosting of Circular and Notice of GM
30th Mar 20217:01 amRNSChange of Name and Share Capital Reorganisation
30th Mar 20217:00 amRNSTrading Update
30th Nov 20207:00 amRNSHalf-year Report
26th Nov 202011:35 amRNSBoard Changes
12th Oct 20204:23 pmRNSHolding(s) in Company
29th Sep 202012:21 pmRNSResult of AGM
4th Sep 202012:31 pmRNSAnnual Financial Report
3rd Sep 20207:02 amRNSFinal Results
3rd Sep 20207:00 amRNSAppointment of Nominated Adviser and Sole Broker
5th Aug 20202:02 pmRNSHolding(s) in Company
29th Jul 20207:00 amRNSIssue of Shares and Director / PDMR Dealing
1st Jul 202010:52 amRNSDirectorate Change
18th Jun 20207:00 amRNSDr David Hammond
1st Jun 20202:06 pmRNSBoard Appointments
1st Jun 20207:00 amRNSUpdated Debt Facilities
23rd Apr 20207:06 amRNSAppointment of CFO and COVID-19 Update
18th Mar 20205:46 pmRNSAIM Rule 17 Notification
24th Feb 20203:47 pmRNSDirectorate Change
22nd Jan 20202:52 pmRNSDirectorate Change
22nd Jan 20207:00 amRNSTrading Update
29th Oct 20197:00 amRNSHalf-year Report
26th Sep 20197:00 amRNSChange of Adviser
25th Sep 20198:59 amRNSAIM Rule 17 Schedule Two (g) Update
2nd Sep 20197:00 amRNSDirectorate Change
29th Aug 20194:07 pmRNSResult of AGM
23rd Jul 20197:00 amRNSHolding(s) in Company
23rd Jul 20197:00 amRNSHolding(s) in Company
18th Jul 20191:42 pmRNSCompletion of Acquisition
18th Jul 20198:48 amRNSDirector/PDMR Shareholding
18th Jul 20198:46 amRNSAnnual Financial Report
16th Jul 201910:39 amRNSResult of General Meeting and Open Offer
28th Jun 20198:47 amRNSGeneral Meeting & Open Offer Timetable
28th Jun 20197:00 amRNSAcquisition, Fundraising and Notice of GM
28th Jun 20197:00 amRNSFinal Results
11th Jun 20197:00 amRNSAcquisition of Meritgroup
10th Jun 20197:00 amRNSResponse re. Press Speculation
21st May 20197:00 amRNSAppointment of Chief Revenue Officer
29th Apr 20197:00 amRNSAppointment of Chief Information Officer
21st Jan 20197:00 amRNSTrading Statement
5th Dec 20181:50 pmRNSHolding(s) in Company
5th Dec 20181:50 pmRNSHolding(s) in Company
14th Nov 20187:00 amRNSHalf-year Report
21st Sep 201811:17 amRNSLong Term Incentive Plan
14th Aug 201812:39 pmRNSDirectorate Change
7th Aug 20184:14 pmRNSDirector/PDMR Shareholding
1st Aug 20189:52 amRNSDirectorate Change
1st Aug 20189:24 amRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.